Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)
Clinical trial NCT03858049 · TERMINATED
Trial details
- NCT number
- NCT03858049
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2021-10-27
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.